Thailand Biotech News

In addition to the 85,106 reviews it published last week, the online science magazine EurekaMag.com has just released another 46,051 scientific reviews on selected topics of the basic and applied life, earth and health sciences.

One of the most important green renewables trade shows, Solarexpo, is teaming up this year.

Biotrix Asia Company Ltd. hires leading SEO services company Position Front Page International Co., Ltd. to give them a face lift.

stem cell therapy: Hepatitis, Cirrhosis, Cancer of the liver, Wilson's disease, Primary sclerosing cholangitis, Primary biliary cirrhosis, autoimmune disease of small bile ducts, Gilbert's syndrome, Glycogen storage disease type II.

A new treatment approach to cirrhosis and other progressive and debilitating liver diseases has been launched in Bangkok, Thailand. This is good news for sufferers who want a better quality of life.

Using umbilical cord blood-derived stem cells in combination with dietary supplements may enhance brain tissue development in patients with Down syndrome.

A new protocol for the treatment of Osteoarthritis, using umbilical cord blood-derived adult stem cells in the treatment program, is now available in Bangkok, Thailand. Patients can reasonably expect less pain and improved mobility.

sophisticated medical check-up that tracks your health with Biomolecular Resonance Image Technology and Live Blood Analysis

A 34 year old Bangladeshi electronic hardware engineer, resident in the Middle East, who is a paraplegic after tumor surgery, travelled to Bangkok in the hope of regaining some sensation and control.

Siam Life Science (Thailand) and Walter Reed Army Institute of Research (USA) develop new gold standard for pharmacological and toxicological test systems.

Patients suffering from a range of debilitating illnesses, such as spinal cord injury, cerebral palsy, optic nerve hypoplasia, multiple sclerosis and ataxia stand to benefit from a new laboratory, established with a Chinese Government grant.

Millions of cardiomyopathy patients have been told their future lies in drugs or a transplant as they await an otherwise certain death. This is no longer true as Theravitae’s VesCell therapy is giving some 68 percent of them a new life.